Enzo Biochem Inc (ENZ) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Enzo Biochem Inc (ENZ) has a cash flow conversion efficiency ratio of -0.074x as of April 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-3.22 Million) by net assets ($43.40 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See ENZ equity financing ratio to measure how much of total assets are equity-financed.
Enzo Biochem Inc - Cash Flow Conversion Efficiency Trend (1989–2024)
This chart illustrates how Enzo Biochem Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Enzo Biochem Inc earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Enzo Biochem Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Enzo Biochem Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Genenta Science SpA ADR
NASDAQ:GNTA
|
-0.077x |
|
Y&G Corp Bhd
KLSE:7003
|
0.051x |
|
PNC Technologies co. Ltd
KQ:237750
|
0.017x |
|
Natural Health Trend
NASDAQ:NHTC
|
-0.048x |
|
BR.SCH.ED.HLD.SP.ADR CL.A
F:BSK0
|
N/A |
|
Image Resources NL
AU:IMA
|
0.024x |
|
Barrel Co. Ltd
KQ:267790
|
-0.054x |
|
Dev Information Technology Limited
NSE:DEVIT
|
0.054x |
Annual Cash Flow Conversion Efficiency for Enzo Biochem Inc (1989–2024)
The table below shows the annual cash flow conversion efficiency of Enzo Biochem Inc from 1989 to 2024. For the full company profile with market capitalisation and key ratios, see Enzo Biochem Inc market cap and net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-07-31 | $56.11 Million | $-26.26 Million | -0.468x | +0.70% |
| 2023-07-31 | $78.46 Million | $-36.98 Million | -0.471x | -54.71% |
| 2022-07-31 | $54.46 Million | $-16.59 Million | -0.305x | -5498.55% |
| 2021-07-31 | $68.59 Million | $387.00K | 0.006x | +101.92% |
| 2020-07-31 | $58.38 Million | $-17.18 Million | -0.294x | -626.72% |
| 2019-07-31 | $86.03 Million | $4.81 Million | 0.056x | +265.70% |
| 2018-07-31 | $81.12 Million | $-2.73 Million | -0.034x | -1361.62% |
| 2017-07-31 | $88.87 Million | $-205.00K | -0.002x | -100.39% |
| 2016-07-31 | $89.55 Million | $53.13 Million | 0.593x | +783.11% |
| 2015-07-31 | $42.61 Million | $-3.70 Million | -0.087x | -89.09% |
| 2014-07-31 | $36.95 Million | $-1.70 Million | -0.046x | +84.35% |
| 2013-07-31 | $34.13 Million | $-10.02 Million | -0.293x | -141.27% |
| 2012-07-31 | $49.10 Million | $-5.97 Million | -0.122x | -29.60% |
| 2011-07-31 | $88.72 Million | $-8.33 Million | -0.094x | +32.37% |
| 2010-07-31 | $97.02 Million | $-13.46 Million | -0.139x | -41.21% |
| 2009-07-31 | $116.78 Million | $-11.48 Million | -0.098x | -58.70% |
| 2008-07-31 | $138.29 Million | $-8.56 Million | -0.062x | -133.33% |
| 2007-07-31 | $141.89 Million | $-3.77 Million | -0.027x | +74.94% |
| 2006-07-31 | $95.59 Million | $-10.12 Million | -0.106x | -189.40% |
| 2005-07-31 | $108.27 Million | $12.83 Million | 0.118x | +321.11% |
| 2004-07-31 | $104.17 Million | $-5.58 Million | -0.054x | -148.36% |
| 2003-07-31 | $109.38 Million | $12.12 Million | 0.111x | +21.42% |
| 2002-07-31 | $104.73 Million | $9.56 Million | 0.091x | +11.29% |
| 2001-07-31 | $97.52 Million | $8.00 Million | 0.082x | +44.96% |
| 2000-07-31 | $87.18 Million | $4.93 Million | 0.057x | -61.47% |
| 1999-07-31 | $75.60 Million | $11.10 Million | 0.147x | +21.71% |
| 1998-07-31 | $68.80 Million | $8.30 Million | 0.121x | +0.27% |
| 1997-07-31 | $64.00 Million | $7.70 Million | 0.120x | +9.07% |
| 1996-07-31 | $55.30 Million | $6.10 Million | 0.110x | -25.94% |
| 1995-07-31 | $61.10 Million | $9.10 Million | 0.149x | +338.30% |
| 1994-07-31 | $51.20 Million | $-3.20 Million | -0.063x | -352.34% |
| 1993-07-31 | $32.30 Million | $800.00K | 0.025x | -61.08% |
| 1992-07-31 | $33.00 Million | $2.10 Million | 0.064x | +103.04% |
| 1991-07-31 | $1.10 Million | $-2.30 Million | -2.091x | -420.68% |
| 1990-07-31 | $12.70 Million | $-5.10 Million | -0.402x | -29.02% |
| 1989-07-31 | $15.10 Million | $-4.70 Million | -0.311x | -- |
About Enzo Biochem Inc
Enzo Biochem, Inc., a life sciences company, engages in the labeling and detection technologies from DNA to whole cell analysis in the United States and internationally. The company offers labels, dyes, antibodies, genomic probes, immunoassays, biochemicals, and proteins are used to label, detect, and visualize a biological target of interest in drug discovery exploration and drug development pro… Read more